Global Statistics

All countries
162,303,342
Confirmed
Updated on May 14, 2021 1:26 pm
All countries
141,218,507
Recovered
Updated on May 14, 2021 1:26 pm
All countries
3,365,663
Deaths
Updated on May 14, 2021 1:26 pm
Friday, May 14, 2021

Global Statistics

All countries
162,303,342
Confirmed
Updated on May 14, 2021 1:26 pm
All countries
141,218,507
Recovered
Updated on May 14, 2021 1:26 pm
All countries
3,365,663
Deaths
Updated on May 14, 2021 1:26 pm
Molderizer and Safe Shield

The Most Common Lingering Symptoms After Mild COVID

Imported Sputnik V Vaccine to Cost Rs 995.40 Per Shot, Made-in-India Doses May be Cheaper

Coronavirus News LIVE Updates: An imported dose of Russia’s Sputnik V vaccine against coronavirus will cost ₹ 995.40 in India, Dr Reddy’s Laboratories,...

Blood donation desparately needed in California as supplies dwindle during coronavirus pandemic

Mark S. Allen went to Vitalant in Roseville to get a sense of the urgency on the low blood supply in California. And he...

What will be the cost of the Coronavirus vaccine in Pakistan?

CostOfCoronavirusVaccine COVID19VaccineInPakistan #CoronavirusVaccine #IqrarUlHassan #SareAam What will be the cost of the Coronavirus vaccine in ... source

Coronavirus is airborne so stop disinfecting everything: expert

Stop cleaning and start ventilating — that's the message from Micheal Brauer, a professor in the School of Population and Public Health at...

Markets slump as Singapore brings in strictest COVID-19 curbs since lockdown

Office workers scan a Safe Entry QR code to enter a mall, amid the coronavirus disease (COVID-19) outbreak in Singapore May 12, 2021....


April 12, 2021 – Loss of smell, loss of taste, shortness of breath, and fatigue are the four most common symptoms that people reported 8 months after a mild case of COVID-19, according to a new study.

Approximately 1 in 10 people experienced at least one moderate-to-severe symptom that negatively affected their quality of life.

“Even if you are young and previously healthy, a mild COVID-19 infection may result in long-term consequences,” said senior author Charlotte Thålin, MD, , from the department of clinical sciences at Danderyd Hospital of the Karolinska Institute in Stockholm, Sweden.

Thålin and colleagues tracked the COVID-19-related experiences of more than 1,000 health care workers in Sweden over the past year, and published their most recent results in JAMA, the journal of the American Medical Association.

The researchers found no increase of cognitive issues — including memory or concentration — that others have linked to what’s often called long-haul COVID-19. The researchers also did not observe an increased risk for long-term symptoms after asymptomatic COVID-19 cases.

Previous research found severe long-term symptoms, including heart palpitations and neurologic impairments, among people hospitalized with COVID-19. The absence of these more severe symptoms after mild COVID-19 is “reassuring,” Thålin said.


Adding to Existing Evidence

This research “adds to the growing body of literature showing that people recovering from COVID have reported a diverse array of symptoms lasting for months after initial infection,” said Lekshmi Santhosh, MD, doctor faculty lead at the University of California, San Francisco Post-COVID OPTIMAL Clinic.

The current findings are part of an ongoing study looking at long-term immunity. Health care professionals enrolled in the research between April 15 and May 8, 2020, and have blood tests for coronavirus antibodies every 4 months. The researchers compared the symptoms participants with mild cases of COVID-19 reported with those who never tested positive for coronavirus antibodies.

The results show that 26% of those who had COVID-19 previously had at least one moderate-to-severe symptom that lasted more than 2 months, compared with 9% in the control group. Of the people with mild COVID-19 cases, 11% reported at least one symptom that negatively affected work, social, or home life after 8 months, vs only 2% of the control group.


“These data mirror what we have seen across long-term cohorts of patients with COVID-19 infection. Notably, mild illness among previously healthy individuals may be associated with long-term persistent symptoms,” said Sarah Jolley, MD, a pulmonologist specializing in critical care at UCHealth University of Colorado Hospital in Aurora and director of the Post-COVID Clinic.

“In this cohort, similar to others, this seems to be more pronounced in women,” Jolley added.

The study’s findings “tracks with a lot of the other work we’re seeing,” said David Putrino, PhD, director of rehabilitation innovation at Mount Sinai Health System in New York City, who works with patients with long COVID.

Interestingly, the number of people with persistent symptoms might be underestimated in this research, Putrino said. “Antibodies are not an entirely reliable biomarker. So what the researchers are using here is the most conservative measure of who may have had the virus.”

Furthermore, unlike many of the people with long-haul COVID-19 he treats— ones who are “really struggling” — the health care workers studied in Sweden are functioning well enough to perform their duties at the hospital, so the study group may not represent the general population.

“We’re really just starting to understand the long-term effects of COVID-19,” Putrino said. “This is something we’re going to see a lot of moving forward.”



Medscape Medical News


© 2021 WebMD, LLC. All rights reserved.





Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Popular

Imported Sputnik V Vaccine to Cost Rs 995.40 Per Shot, Made-in-India Doses May be Cheaper

Coronavirus News LIVE Updates: An imported dose of Russia’s Sputnik V vaccine against coronavirus will cost ₹ 995.40 in India, Dr Reddy’s Laboratories,...

Blood donation desparately needed in California as supplies dwindle during coronavirus pandemic

Mark S. Allen went to Vitalant in Roseville to get a sense of the urgency on the low blood supply in California. And he...

What will be the cost of the Coronavirus vaccine in Pakistan?

CostOfCoronavirusVaccine COVID19VaccineInPakistan #CoronavirusVaccine #IqrarUlHassan #SareAam What will be the cost of the Coronavirus vaccine in ... source

Related Articles

Imported Sputnik V Vaccine to Cost Rs 995.40 Per Shot, Made-in-India Doses May be Cheaper

Coronavirus News LIVE Updates: An imported dose of Russia’s Sputnik V vaccine against coronavirus will cost ₹ 995.40 in India, Dr Reddy’s Laboratories,...

Blood donation desparately needed in California as supplies dwindle during coronavirus pandemic

Mark S. Allen went to Vitalant in Roseville to get a sense of the urgency on the low blood supply in California. And he...

What will be the cost of the Coronavirus vaccine in Pakistan?

CostOfCoronavirusVaccine COVID19VaccineInPakistan #CoronavirusVaccine #IqrarUlHassan #SareAam What will be the cost of the Coronavirus vaccine in ... source